GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM

大急流城临床肿瘤学项目

基本信息

批准号：
6375677
负责人：
KATHLEEN J YOST
金额：
$ 78.05万
依托单位：
SPECTRUM HEALTH HOSPITALS
依托单位国家：
美国
项目类别：
财政年份：
2000
资助国家：
美国
起止时间：
2000-06-01 至 2005-05-31
项目状态：
已结题

项目摘要

Building on nearly 25 years of experience as a model community oncology program, the Grand Rapids Clinical Oncology Program (GRCOP) seeks the opportunity to continue to meet our community's need for innovative and relevant studies of promising therapeutic modalities and cancer control research into the next decade. The GRCOP is a regional clinical trials program: a consortium of 7 hospitals within a 38 county service area in Western Michigan. Six component hospitals and one affiliate hospital bring together investigators from 5 cities: Grand Rapids, Holland, Battle Creek, Big Rapids, and Traverse City. The accrual service area represents over 26 percent of the state's metropolitan and rural populations. The GRCOP provides the only access to clinical trials in rural counties with low population density. The goal of the Grand Rapids Clinical Oncology Program is to contribute to scientific knowledge and to enhance the level of care in the community through participation in NCI sponsored clinical treatment and cancer control trials. Several aims describe the long-term objectives: to mobilize the existing GRCOP service area resources to increase accrual on NCI protocol studies, including minorities, women, and underserved populations; to provide our Grand Rapids CCOP participants an important opportunity to contribute to national research goals by providing access to the full range of available protocols by our continued work with our CCOP Research Bases (SWOG, CCG, NSABP, MDACC, and University of Michigan); to expand our longstanding commitment to cancer prevention and control research, exceeding our past record and retaining adherent participants for the duration of the BCPT and PCPT; and to promote the involvement of both primary care providers and other specialists in cancer prevention and control clinical trials. The methods used to achieve these goals include an extensive GRCOP network, a solid organizational base, and an outstanding data management program. Our GRCOP network incorporates strong links among the medical oncologists (46), multidisciplinary contributors (50), primary care collaborators (170), and member hospitals (7) within a tightly woven series of community healthcare programs and resources. This network is supported by a solid organizational structure for both the adult and pediatric components; a proven and comprehensive data management system for the timely collection and transmission of data to our five research bases; and ongoing Quality Control and Assurance programs to assure the highest possible data quality to our research bases for use in analyses and publications. The GRCOP expects to accumulate over 360 credits per year: with over 125 treatment credits and over 234 cancer control credits.

大急流城临床肿瘤学计划（GRCOP）以近25年的经验作为模型社区肿瘤学计划，寻求有机会继续满足我们社区对未来十年中有希望的治疗方式和癌症控制研究的创新和相关研究的需求。 GRCOP是一项区域临床试验计划：密歇根州西部38个县服务区内的7家医院的财团。六家组件医院和一家分支机构医院将来自5个城市的调查员聚集在一起：大急流城，荷兰，巴特尔克里克，大急流城和特拉弗斯城。应计服务区占该州大都市和农村人口的26％以上。 GRCOP在人口密度低的农村县提供了唯一的临床试验访问权限。大急流城临床肿瘤学计划的目标是通过参加NCI赞助的临床治疗和癌症控制试验来为科学知识做出贡献，并提高社区的护理水平。几个目的描述了长期目标：动员现有的GRCOP服务区域资源以增加NCI协议研究的应计，包括少数民族，妇女和服务不足的人口；通过我们与CCOP研究基地（SWOG，CCG，NSABP，MDACC和密歇根大学）的合作，为我们的大急流城CCOP参与者提供了为国家研究目标做出贡献的重要机会；为了扩大我们对预防癌症预防和控制研究的长期承诺，超越了我们过去的记录并在BCPT和PCPT期间保留了坚持参与者；并促进初级保健提供者和其他专家参与癌症预防和控制临床试验。用于实现这些目标的方法包括广泛的GRCOP网络，可靠的组织基础和出色的数据管理计划。我们的GRCOP网络在医学肿瘤学家（46），多学科贡献者（50），初级保健合作者（170）和会员医院（7）中结合了牢固的联系，并在一系列紧密编织的社区医疗保健计划和资源中。该网络得到了成人和小儿组件的扎实组织结构的支持。及时将数据传输到我们的五个研究基础上的经过验证和全面的数据管理系统；以及正在进行的质量控制和保证计划，以确保我们的研究基础的最高数据质量用于分析和出版物。 GRCOP预计每年将积累360多个学分：拥有超过125个治疗学分和234多个癌症控制学分。